Come up with a name for your new list and we'll add to it:
MabLyte raised a round of funding on April 11, 2013. Investors include
Mercia Fund Management.
MabLyte is a life science, diagnostics company that will produce a range of kits for the analysis of the biological activity of monoclonal antibodies (widely used for the treatment of disease in man) …